Literature DB >> 9400789

Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina.

C J Pournaras1, J W Miller, E S Gragoudas, D Husain, J L Munoz, M J Tolentino, M Kuroki, A P Adamis.   

Abstract

OBJECTIVES: To determine whether systemic hyperoxia can reverse retinal hypoxia and decrease vascular endothelial growth factor (VEGF) gene expression in ischemic nonhuman primate retina.
METHODS: Six eyes of 3 cynomolgus monkeys were studied. Retinal ischemia was induced via laser vein occlusion and confirmed with fluorescein angiography. Animals were randomly assigned to treatment with either 21% or 100% inhaled oxygen. Arterial PO2 was monitored while systemic acid-base status was maintained. An oxygen microelectrode on a micromanipulator was used to measure preretinal oxygen concentrations in ischemic and nonischemic retina in situ. RNA was isolated from fresh whole retinas, and VEGF messenger RNA levels were quantified with Northern blotting.
RESULTS: The preretinal PO2 in ischemic retina was less than the PO2 in nonischemic retina in animals breathing 21% oxygen (intervascular zone PO2, 14.3+/-0.53 vs 21.8+/-0.55 mm Hg; P=.002). After 8 hours of systemic hyperoxia (arterial PO2, 512+/-18 mm Hg), the preretinal PO2 in ischemic retina increased to 166.2+/-15.6 mm Hg (21.8% oxygen) and retinal VEGF messenger RNA levels were reduced by an average of 55%.
CONCLUSIONS: These data demonstrate that systemic hyperoxia can lower retinal VEGF gene expression and reoxygenate ischemic adult primate retina.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400789     DOI: 10.1001/archopht.1997.01100160723009

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  Systemic oxygen therapy versus oral enalapril for treatment of diabetic macular ischemia: a randomized controlled trial.

Authors:  Farideh Sharifipour; Mohammadreza Razzaghi; Alireza Ramezani; Mohsen Azarmina; Mehdi Yaseri; Roham Soheilian; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2015-08-21       Impact factor: 2.031

Review 2.  Retinal oxygen: from animals to humans.

Authors:  Robert A Linsenmeier; Hao F Zhang
Journal:  Prog Retin Eye Res       Date:  2017-01-18       Impact factor: 21.198

3.  Oxysterol-induced toxicity in R28 and ARPE-19 cells.

Authors:  John M Ong; Annette M Aoki; Gail M Seigel; Ingrid Sacerio; Raquel Castellon; Anthony B Nesburn; M Cristina Kenney
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

4.  Study of retinal vessel oxygen saturation in ischemic and non-ischemic branch retinal vein occlusion.

Authors:  Lei-Lei Lin; Yan-Min Dong; Yao Zong; Qi-Shan Zheng; Yue Fu; Yong-Guang Yuan; Xia Huang; Garrett Qian; Qian-Ying Gao
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

5.  Zeaxanthin inhibits hypoxia-induced VEGF secretion by RPE cells through decreased protein levels of hypoxia-inducible factors-1α.

Authors:  Richard Rosen; Tommaso Vagaggini; Yueqin Chen; Dan-Ning Hu
Journal:  Biomed Res Int       Date:  2015-01-20       Impact factor: 3.411

Review 6.  The Vitreomacular Interface in Diabetic Retinopathy.

Authors:  Daniel Agarwal; Rachel Gelman; Claudia Prospero Ponce; William Stevenson; John B Christoforidis
Journal:  J Ophthalmol       Date:  2015-09-03       Impact factor: 1.909

7.  Retinal Oxygen Delivery and Metabolism Response to Hyperoxia During Bilateral Common Carotid Artery Occlusion in Rats.

Authors:  Sophie Leahy; Nathanael Matei; Norman P Blair; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

8.  Rapid reduction of macular edema due to retinal vein occlusion with low-dose normobaric hyperoxia.

Authors:  Jorge G Arroyo; Brendan Seto; Keiko Yamada; Ke Zeng; Robert Minturn; Colin A Lemire
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-22       Impact factor: 3.117

9.  Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization.

Authors:  Alessandra Puddu; Roberta Sanguineti; Arianna Durante; Massimo Nicolò; Giorgio L Viviani
Journal:  Mol Vis       Date:  2012-10-11       Impact factor: 2.367

10.  Triamcinolone acetonide modulates TGF‑β2‑induced angiogenic and tissue‑remodeling effects in cultured human retinal pigment epithelial cells.

Authors:  Chih-Cheng Hsiao; Yo-Chen Chang; Yu-Ting Hsiao; Po-Han Chen; Ming-Chu Hsieh; Wen-Chuan Wu; Ying-Hsien Kao
Journal:  Mol Med Rep       Date:  2021-09-15       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.